|New Playbook from Tive & BioPharma Dive: "How to Reduce Product Loss & Achieve a More Sustainable Pharma Supply Chain"|
|By: PR Newswire Association LLC. - 31 May 2023||Back to overview list
Safeguarding these vital supplies during transit protects people's health and contributes to the preservation of the environment
BOSTON, May 31, 2023 /PRNewswire/ -- Tive, the global leader in real-time supply chain visibility solutions, today announced a new playbook created in conjunction with experts from BioPharma Dive. This free playbook, entitled "How to Reduce Product Loss & Achieve a More Sustainable Pharma Supply Chain," spotlights how pharmaceutical brands, shippers, and Logistics Service Providers (LSPs) can implement sustainable shipping practices throughout their supply chain.
The transportation industry generates 17% of total global greenhouse gas (GHG) emissions worldwide, and 28% of total U.S. emissions alone—more than any other economic segment—and protecting these valuable products during delivery helps reduce the environmental impact. In-shipment temperature failures are responsible for $35 billion in product losses, and manufacturing and transporting replacement products can more than double the GHG emissions of the original shipment.
Key takeaways from this new playbook include:
"It is critical to protect pharmaceutical shipments—to ensure not just the health and well being of individuals, but also the health of our environment," said Krenar Komoni, Tive CEO and Founder. "This playbook explains why safeguarding these vital supplies during transit helps both the planet and a company's bottom line—leading to a sustainable path towards a healthier world for generations to come."
A free copy of this playbook is available for download here.
View original content to download multimedia:https://www.prnewswire.com/news-releases/new-playbook-from-tive--biopharma-dive-how-to-reduce-product-loss--achieve-a-more-sustainable-pharma-supply-chain-301837460.html
SOURCE Tive, Inc.
Copyright 2023 PR Newswire Association LLC.
|Back to overview list|